WHO good practices for research and development facilities of pharmaceutical products.

The article discuses the World Health Organization (WHO) good practices for research and development facilities of pharmaceutical products. It is reported that the aim of the document is to ensure appropriateness, reliability, quality of products, processes, procedures and data. It is further reported that principles described in this document is applied in facilities where products such as biopharmaceutical products, vaccines and medical devices, are manufactured.